2Fiehn O. Metabolomics - the link between genotypes and phenotypes. Plant Mol Biol,2002,48( 1 ) :155 - 171
3German JB,Bauman DE,Burrin DG, et al. Mtabolomics in the opening decade of the 21^st century: building the wade to individualized heahh. J Nute,2004,134 (12) :2729 - 2732
4Henty CM. New "OMR" in town chem. Eng News ,2002,80 (1) :66 -70
7Iorio E, Mezzanzanica D, Alberti P, et al. Alterations of choline phospholipid metabolism in ovarian fumor progression. Cancer Res,2005, 65(10) :9369 -9375
8Odunsi K,Wollman RM, Ambrosone CB, et al. Defection of epithelial ovarian cancer using ^1H - NMR based metabonomics. Int J Cancer, 2005,13(7) :782 -778
9Denkert C, Budczies J, Kind T,et al. Mass spectrometry = based metabolic profiling reveals - different metabolite Patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res,2006,66 (10) : 10795 - 10804
3Sitter B, Bathen T, Hagen B, et al. Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy. MAGMA, 2004, 16:174-181.
4Lyng H, Sitter B, Bathen TF, et al. Metabolic mapping by use of high-resolution magic angle spinning ^1H MR spectroscopy for assessment of apoptosis in cervical carcinomas. BMC Cancer, 2007,7:11.
5Griffin JL, Pole JC, Nicholson JK, et al. Cellular environment of metabolites and a metabonomic study of tamoxifen in endometrial cells using gradient high resolution magic angle spinning ^1H NMR spectroscopy. Biochim Biophys Acta, 2003,1619 : 151-158.
6Wallace JC, Raaphorst GP, Somorjai RL, et al. Classification of H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis. Magn Reson Med,1997,38:569-576.
7Massuger LF, Vierzen PB, Engelke U, et al. ^1 H-magnetic resonance spectroscopy: a new technique to discriminate benign from malignant ovarian tumors. Cancer, 1998,82 : 1726-1730.
8Cho SW,- Cho SG, Lee JH, et al. In-vivo proton magnetic resonance spectroscopy in adnexal lesions. Korean J Radiol, 2002,3 : 105-112.
9Iofio E, Mezzanzanica D, Alberti P, et al. Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res, 2005,65:9369-9376.
10Odunsi K, Wollman RM, Ambrosone CB, et al. Detection of epithelial ovarian cancer using ^1H-NMR-based metabonomics. Int J Cancer, 2005,113:782-788.
